With the multitude of complex issues associated with clinical trials in diabetes, it is clear that there is a necessity to streamline these issues into a process that will improve drug development in terms of approval and commercialization, and address the various aspects of drug and device development and the way to enhance them.
Through a comprehensive scientific program, The World Congress on Clinical Trials in Diabetes will focus on four key areas:
- Design the Best Study
- Improve Regulatory Process; Better Understanding of How to Collaborate with Regulatory Authorities
- Involvement of Digital Medicine
- Power Post-Marketing Surveillance
